Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

Healthcare Biotechnology
StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

StageZero Life Sciences Ltd > Institutional Accumulation SZLS
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(41)
•••
Comment by LithLoveron Sep 21, 2021 4:45pm
217 Views
Post# 33893877

RE:RE:Institutional Accumulation SZLS

RE:RE:Institutional Accumulation SZLSWell well who figured Fidelity would show up to keep buying  lol


15:39:49 T 0.385 0.01 5,000 22 Fidelity 80 National Bank K
15:39:49 T 0.385 0.01 1,000 22 Fidelity 7 TD Sec K
15:39:49 T 0.385 0.01 3,000 22 Fidelity 33 Canaccord K
15:39:49 T 0.385 0.01 1,000 22 Fidelity 5 Penson K

LithLover wrote: Pershing on the buy again this morning and I'm Fidelity will show up later

09:39:35 T 0.38 0.005 6,000 143 Pershing 1 Anonymous K
09:34:34 M 0.39 0.015 35 80 National Bank 80 National Bank E
09:30:00 T 0.38 0.005 10 33 Canaccord 85 Scotia  
09:30:00 T 0.38 0.005 130 5 Penson 80 National Bank  
09:30:00 T 0.38 0.005 6,000 143 Pershing 80 National Bank KL
Pershing 143:

Service(s)
 
  • Institutional Clearing
  • Institutional Trading

 
Photoman77 wrote: Institutional Accumulation happening through Pershing Securities 143 & Fidelity 22

They have to have a few million shares now between the two.

Once the accumulation is done you will see the movement upwards.

Don't let them convince you otherwise.

Moniter for yourself here 9check out recent trades daily):

https://www.stockwatch.com/Quote/Detail?C:SZLS 




<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities